Moleculin Biotech files to sell 64.86M shares of common stock by selling shareholder

* Moleculin Biotech (NASDAQ:MBRX [https://seekingalpha.com/symbol/MBRX]) filed to sell 64.86 million common stock.
* This prospectus is not an offer to sell these securities.
* The company will not receive any proceeds from the sale of common stocks by the selling shareholder.
* Filing [https://seekingalpha.com/filing/10436249]

MORE ON MOLECULIN BIOTECH

* Moleculin receives notice of intent to grant new European patent for Annamycin [https://seekingalpha.com/news/4474262-moleculin-receives-notice-of-intent-to-grant-new-european-patent-for-annamycin]
* Seeking Alpha’s Quant Rating on Moleculin Biotech [https://seekingalpha.com/symbol/MBRX/ratings/quant-ratings]
* Historical earnings data for Moleculin Biotech [https://seekingalpha.com/symbol/MBRX/earnings]
* Financial information for Moleculin Biotech [https://seekingalpha.com/symbol/MBRX/income-statement]